U.S. Paper and Forestry Products Stock News

NasdaqGS:CAPR
NasdaqGS:CAPRBiotechs

How Investors May Respond To Capricor Therapeutics (CAPR) Deramiocel Regulatory Uncertainty After Wider Q1 Loss

Capricor Therapeutics reported a first-quarter 2026 net loss of US$33.94 million, with basic loss per share from continuing operations of US$0.59, and also prepared to present at investor and patient conferences later in May. Analyst commentary highlighting optimism for potential FDA approval of Deramiocel alongside fresh uncertainty over its commercialization timing and milestones has become a key focus for investors reassessing Capricor’s outlook. We’ll now examine how the emerging...
NasdaqCM:BTBT
NasdaqCM:BTBTSoftware

Assessing Bit Digital (BTBT) Valuation After Earnings Loss And New Investor Relations Hire

Bit Digital (BTBT) is back on investors' radar after first quarter results showed revenue of US$27.92 million and a net loss of US$146.67 million, alongside the appointment of a new Head of Investor Relations. See our latest analysis for Bit Digital. At a share price of US$1.94, Bit Digital has seen a 10.23% 1 day share price return and an 18.29% 90 day share price return, yet its 1 year total shareholder return is still down 22.40%. This suggests recent momentum is picking up after a weaker...
NYSE:SFL
NYSE:SFLOil and Gas

Should SFL’s (SFL) Higher Dividend and Extended Buyback Plan Require Action From Investors?

SFL Corporation Ltd. has already reported first-quarter 2026 results, posting revenue of US$174.48 million, net income of US$26.08 million, basic earnings per share of US$0.20, and declaring a quarterly cash dividend of US$0.22 per share payable around June 22, 2026, while extending its share buyback plan to June 2028. Together, the higher cash dividend and extended buyback plan point to management’s confidence in SFL’s cash-generating capacity and its commitment to ongoing shareholder...
NYSE:KIM
NYSE:KIMRetail REITs

Is Alleged Lease Fraud Around Target Redevelopment Altering The Investment Case For Kimco Realty (KIM)?

In May 2026, Drip Coffee sued Kimco Realty in a Florida state court, alleging the REIT fraudulently induced multi‑year leases while concealing plans to demolish over 100,000 square feet of a shopping center to accommodate a Target redevelopment. The case raises questions about Kimco’s tenant‑relations practices and disclosure around redevelopment projects, issues that sit at the core of its open‑air shopping center business model. We’ll now examine how allegations that Kimco concealed...
NasdaqGS:BPOP
NasdaqGS:BPOPBanks

The Bull Case For Popular (BPOP) Could Change Following Governance Amendments And Sustained Dividend Payouts – Learn Why

Earlier in May 2026, Popular, Inc. approved amendments to its Restated Certificate of Incorporation in Puerto Rico, including updated indemnification and director election provisions, while also declaring a quarterly cash dividend of US$0.75 per common share payable on July 1, 2026. These governance changes, paired with an ongoing performance-focused culture and heightened options-market activity, point to a company tightening internal accountability while attracting fresh investor...
NYSE:CHH
NYSE:CHHHospitality

A Look At Choice Hotels International (CHH) Valuation After Recent Mixed Share Price Performance

Recent performance snapshot Choice Hotels International (CHH) has drawn attention after mixed recent returns, with the stock down about 7% over the past month but up roughly 1% over the past 3 months and 16% year to date. That backdrop sits alongside annual revenue of US$987.8m and net income of US$344.1m, supported mainly by its Hotel Franchising & Management segment. Investors are assessing how the hotel franchisor’s fundamentals align with recent share price moves. See our latest analysis...
NYSE:BNT
NYSE:BNTInsurance

A Look At Brookfield Wealth Solutions (BNT) Valuation After Weaker First Quarter Revenue And Wider Net Loss

Brookfield Wealth Solutions (BNT) is back in focus after first quarter results showed revenue of US$1,656 million compared with US$2,618 million a year earlier, alongside a net loss that widened from US$326 million to US$609 million. See our latest analysis for Brookfield Wealth Solutions. At a share price of US$45.35, the stock has seen a 7 day share price return that declined 4.6% and a year to date share price return that declined 2.9%. By contrast, the 1 year total shareholder return of...
NasdaqGM:GCT
NasdaqGM:GCTRetail Distributors

Is It Too Late To Consider GigaCloud Technology (GCT) After A 106% One Year Surge?

Wondering if GigaCloud Technology at around US$38.55 is still offering value, or if the big gains are already behind it? This article breaks down what the current price might be implying about the stock. The stock has risen 4.0% over the past week, even though it is down 18.7% over the last 30 days and slightly down 0.5% year to date, while still showing a very large 1 year return of 105.9% and an even larger 3 year return. Recent coverage has focused on GigaCloud Technology as a fast...
NYSE:PSA
NYSE:PSASpecialized REITs

Is Public Storage (PSA) Offering Value After Its Recent Share Price Strength?

Wondering if Public Storage at about US$304.99 a share offers fair value or if the price is out of line with the fundamentals? This article breaks down what the market is currently implying. The stock has delivered a 0.6% return over the last week, is down 1.1% over the past month, and is up 18.0% year to date, with a 7.5% return over the past year that sits alongside 21.8% and 35.3% returns over the past 3 and 5 years. Recent coverage has focused on Public Storage as a large self storage...
NYSE:TMO
NYSE:TMOLife Sciences

Thermo Fisher’s New Sweden Lab Deepens Role In Global Drug Development

Thermo Fisher Scientific (NYSE:TMO) has opened a new bioanalytical and biomarker laboratory in Gothenburg, Sweden. The facility is designed to support pharmaceutical and biotechnology companies across all stages of drug development. The lab is connected to Thermo Fisher Scientific's global network of drug development services. Thermo Fisher Scientific, trading at around $449.37, sits at the crossroads of tools, services, and outsourced support that many drug developers rely on. The stock is...
NasdaqGM:RLAY
NasdaqGM:RLAYBiotechs

Relay Therapeutics (RLAY) Is Up 6.9% After Zovegalisib Phase 2 Data And Equity Raise - Has The Bull Case Changed?

Earlier in May 2026, Relay Therapeutics completed a US$275,000,004 follow-on equity offering at US$12 per share after releasing initial Phase 2 ReInspire data showing zovegalisib achieved a 60% volumetric response rate and broad symptom improvement in PIK3CA‑driven vascular anomalies with a safety profile supportive of chronic dosing. An interesting angle is that zovegalisib is being advanced simultaneously in rare vascular anomalies and in an ongoing Phase 3 program for metastatic breast...
NasdaqGS:TARS
NasdaqGS:TARSPharmaceuticals

Assessing Tarsus Pharmaceuticals (TARS) Valuation After New TP-05 Phase 2b Lyme Disease Trial Update

Clinical update on TP-05 puts Tarsus Pharmaceuticals (TARS) in focus Tarsus Pharmaceuticals (TARS) recently updated investors on its ongoing Phase 2b trial of TP-05, an oral tablet being tested to help prevent Lyme disease in high risk individuals. See our latest analysis for Tarsus Pharmaceuticals. The recent TP-05 update comes as Tarsus trades at US$63.48, with the share price down 21.41% year to date but a 1 year total shareholder return of 47.73% and a very large 3 year total shareholder...
NasdaqGM:HPK
NasdaqGM:HPKOil and Gas

A Look At HighPeak Energy (HPK) Valuation As Oil Prices Break Above $100 On Geopolitical Tensions

Oil price shock and HighPeak Energy's stock reaction HighPeak Energy (HPK) moved higher after crude oil prices climbed above $100 a barrel, as mounting geopolitical tensions and potential Strait of Hormuz disruptions fed through to oil linked equities and heightened day to day volatility. See our latest analysis for HighPeak Energy. Beyond the latest oil price shock, HighPeak Energy’s share price has shown strong short term momentum, with a 30 day share price return of 20.46% and a year to...
NYSE:RMD
NYSE:RMDMedical Equipment

How ResMed–Oura Wearable Sleep Data Partnership Could Reshape ResMed's (RMD) Clinical Ecosystem

On 19 May 2026, ResMed and Oura announced a partnership that connects Oura Ring Gen3 and Ring 4 members in the U.S. to ResMed’s sleep education tools, assessments, and options to link with independent healthcare providers. This collaboration uniquely bridges consumer wearable sleep data with clinical sleep resources, aiming to help address undiagnosed conditions such as obstructive sleep apnea. Next, we’ll examine how integrating Oura’s consumer wearables data with ResMed’s clinical sleep...
NasdaqGS:COHU
NasdaqGS:COHUSemiconductor

Is Cohu (COHU) Quietly Reframing Its AI Infrastructure Story With This DiamondX GaN Test Win?

Cohu, Inc. recently reported that a semiconductor manufacturer placed multiple orders totaling approximately US$5,000,000 for its DiamondX test platform, which supports high‑current, ultra‑low resistance measurements and scalable multi‑site throughput for gallium nitride power devices in AI data center power architectures. This win highlights how Cohu is tying its advanced power test capabilities directly to the specific needs of AI data center power conversion, from AC‑DC front ends to...
NYSE:FIG
NYSE:FIGSoftware

Figma (FIG) Valuation Check After Strong Q1 Beat Raised Guidance And AI Growth Momentum

Figma (FIG) is back in focus after first quarter 2026 results topped earnings and revenue expectations, with the company lifting full year revenue guidance and highlighting strong adoption of its AI driven design tools. See our latest analysis for Figma. Despite the strong Q1 reaction, with the stock rallying on earnings and guidance, Figma’s recent share price return tells a mixed story. The 1 month share price return is 15.33%, but the year to date share price return is down 42.60%. This...
NYSE:PFSI
NYSE:PFSIDiversified Financial

How Escalating Legal Probes Into Disclosures Will Impact PennyMac Financial Services (PFSI) Investors

In recent months, PennyMac Financial Services has faced multiple securities law investigations and class action preparations over allegedly misleading disclosures about mortgage refinance recapture rates and business performance, following weaker servicing segment results and heightened competitive pressures. At the same time, a large portion of loans in a new RMBS deal were originated by PennyMac, highlighting how its operational footprint in mortgage origination contrasts with growing...
NYSE:MTDR
NYSE:MTDROil and Gas

Matador Resources Expands Delaware Basin Acreage And Extends Drilling Runway

Matador Resources (NYSE:MTDR) has agreed to acquire over 5,000 net undeveloped acres in the Delaware Basin. The transaction expands the company’s core acreage position and adds to its future drilling inventory. The newly acquired acreage is described as high quality and directly increases Matador’s reserve base. For investors tracking NYSE:MTDR, this acreage deal comes with the stock around $56.09 and a return of 29.4% year to date and 32.6% over the past year. Over a 5-year period, the...
NYSE:CUBE
NYSE:CUBESpecialized REITs

How Investors Are Reacting To CubeSmart (CUBE) Dividend Hike, Earnings Beat And NYC Recovery Update

Earlier this week, CubeSmart’s board declared a past quarterly dividend of US$0.53 per share for the period ended June 30, 2026, payable on July 15 to shareholders of record as of July 1. Alongside the dividend, investors reacted to CubeSmart’s Q1 2026 earnings beat and upbeat New York City operating update, which highlighted a strong recovery in same-store revenue and net rentals. We’ll now examine how the Q1 earnings beat and improving New York City fundamentals may reshape CubeSmart’s...
NYSE:BMI
NYSE:BMIElectronic

The Bull Case For Badger Meter (BMI) Could Change Following Q1 Sales Drop And Fraud Probes – Learn Why

Earlier in 2026, Badger Meter disclosed a year-over-year 9% first-quarter sales decline, especially in utility water products, prompting law firms to investigate potential securities violations tied to its communications on demand and growth. At the same time, the company pressed ahead with its 2026 Investor Day webcast to outline its smart water strategy and long-term framework, underscoring a gap between its growth messaging and recent operational headwinds. Against this backdrop of weaker...
NasdaqGS:LEGN
NasdaqGS:LEGNBiotechs

A Look At Legend Biotech (LEGN) Valuation After Its Strong Q1 2026 Revenue And Narrower Net Loss

Legend Biotech (LEGN) drew fresh attention after reporting first quarter 2026 results, with revenue of US$305.1 million, a narrower net loss of US$54.3 million, and reduced loss per share versus a year earlier. See our latest analysis for Legend Biotech. The quarterly update comes after a sharp 54.47% 90 day share price return and a 30.13% year to date share price gain, contrasting with a 3.65% decline in 1 year total shareholder return and a 55.77% decline over 3 years. This suggests recent...
NasdaqGS:ADUS
NasdaqGS:ADUSHealthcare

A Look At Addus HomeCare (ADUS) Valuation After Recent Share Price Weakness

Addus HomeCare (ADUS) has drawn investor attention after recent trading left the stock around $93.26, with performance mixed over the past year and fundamentals that highlight its position in US home-based care services. See our latest analysis for Addus HomeCare. The recent move to around $93.26 comes after a modest 7 day share price return of 0.92%. However, the 90 day share price return is down 19.24%, and the 1 year total shareholder return is down 16.38%. This points to fading momentum...
NYSE:STT
NYSE:STTCapital Markets

Did Earnings Strength And A Steady Dividend Just Shift State Street's (STT) Investment Narrative?

State Street recently reported strong fourth-quarter 2025 results, highlighted by robust net interest income, margin expansion despite higher operating costs, and a growing backlog of new mandates totaling US$3.60 trillion, while also continuing share repurchases. In parallel, the company has reinforced its capital return profile with a US$0.84 per-share common dividend announced for July 2026 and ongoing preferred dividends, while multiple executives recorded routine tax-related share...
NYSE:ASB
NYSE:ASBBanks

A Look At Associated Banc-Corp (ASB) Valuation After Dallas Commercial Banking Expansion

Associated Banc-Corp (ASB) is expanding its commercial banking footprint in Dallas by adding a dedicated Corporate and Commercial Banking team, hiring experienced local bankers, and doubling its Preston Center office to support broader services. See our latest analysis for Associated Banc-Corp. At a share price of $28.05, Associated Banc-Corp has seen an 8.89% year to date share price return, while its 1 year total shareholder return of 26.09% and 3 year total shareholder return of about 2x...